|Opens resource in a 2nd browser window.|
Gene Therapy Systems, Inc.
(GTS) “Gene Therapy Systems, Inc. is focused on developing revolutionary technology platforms in gene cloning and expression, and in pioneering cell-specific delivery tools.”
GenVec, Inc. focuses on the development and commercialization of novel gene-based therapies for the treatment of major medical needs in cardiovascular disease, cancer and other therapeutic areas.
Introgen Therapeutics, Inc.
Introgen Therapeutics, Inc. develops gene therapy products to treat cancer “in vivo”.
OrthoLogic manufactures and markets a wide variety of proprietary and specialized products for the OrthoCare market, focusing on tissue repair and healing products used by orthopedic surgeons.